RESUMEN

The present study aimed to produce a monosex population of all male Nile tilapia (Oreochromis spp.) using 17α-methyl testosterone and common carp testes (as a source of natural androgen). Trial was conducted into two consecutive phases, the first was fry (4-5 days old)administration with negative control (without hormone) and positive control (with hormone) feed viz., MT1:60mg/kg, MT2:70mg/kg (17α-MT), carp testis CT1:70% and CT2:80% for 30 days to reverse the sex of male fish and the second phase was nursing the fingerlings for two months on control diet (32% Crude protein).Results revealed a significant growth rate (P<0.05) in the control group where final weight (4.8±0.34ab) and weight gained was recorded as 0.66±0.03ac. In proximate chemical composition of body meat, CT2 treatment showed maximum retention of crude protein, crude fat, and ash whereas dry matter showed maximum retention in MT2 and CT1 treatments. Morphological and histological examination revealed significant difference (p<0.05) in phenotypic males of Nile tilapia fed with the highest percent in MT-treated diet (MT2) of 95±0.58a while MT1, CT2 and CT1 had males of 85±6.0b, 70±5.0b and 65±6.5b, respectively. It was concluded that synthetic androgen (17αMT) was more effective for masculinization but natural androgen scan be an alternative method to produce male tilapia population in an environment-friendly manner as they are inexpensive, eco-friendly, and radially available. These results suggested that synthetic and natural androgen supplementation in the diet plays a significant role in improving growth performance and body composition.

O presente estudo teve como objetivo produzir uma população monossexuada de todos os machos de tilápia do Nilo (Oreochromis spp.) usando 17α-metil testosterona e testículos de carpa comum como fonte de andrógeno natural. O ensaio foi conduzido em duas fases consecutivas, a primeira foi a administração de alevinos (4-5 dias) com controle negativo (sem hormônio) e controle positivo (com hormônio), viz., MT1:60mg/kg, MT2:70mg/kg (17α -MT), testículos de carpa CT1:70% e CT2:80% por 30 dias para inverter o sexo dos peixes machos e a segunda fase foi amamentar os alevinos por dois meses com dieta controle (32% de proteína bruta), e analisar a taxa de crescimento (p < 0,05) no grupo controle, em que o peso final (4,8 ± 0,34 ab) e o peso ganho foram registrados como 0,66 ± 0,03 ac. Na composição química aproximada da carne corporal, o tratamento CT2 mostrou retenção máxima de proteína bruta, gordura bruta e cinzas, enquanto a matéria seca apresentou retenção máxima nos tratamentos MT2 e CT1. O exame morfológico e histológico revelou diferença significativa (p < 0,05) nos machos fenotípicos de tilápia do Nilo alimentados com o maior percentual na dieta tratada com MT (MT2) de 95 ± 0,58a enquanto MT1, CT2 e CT1 tiveram machos de 85 ± 6,0b, 70 ± 5,0 e 65 ± 6,5b, respectivamente. Concluiu-se que o andrógeno sintético (17αMT) foi mais eficaz para a masculinização, entretanto os andrógenos naturais podem ser um método alternativo para produzir população de tilápias machos de maneira ecológica, pois são baratos, ecológicos e estão disponíveis radialmente. Esses resultados sugerem que a suplementação de andrógenos sintéticos e naturais na dieta desempenha um papel significativo na melhoria do desempenho do crescimento e da composição corporal.

Asunto(s)

RESUMEN

The present study aimed to produce a monosex population of all male Nile tilapia (Oreochromis spp.) using 17α-methyl testosterone and common carp testes (as a source of natural androgen). Trial was conducted into two consecutive phases, the first was fry (4-5 days old)administration with negative control (without hormone) and positive control (with hormone) feed viz., MT1:60mg/kg, MT2:70mg/kg (17α-MT), carp testis CT1:70% and CT2:80% for 30 days to reverse the sex of male fish and the second phase was nursing the fingerlings for two months on control diet (32% Crude protein).Results revealed a significant growth rate (P<0.05) in the control group where final weight (4.8±0.34ab) and weight gained was recorded as 0.66±0.03ac. In proximate chemical composition of body meat, CT2 treatment showed maximum retention of crude protein, crude fat, and ash whereas dry matter showed maximum retention in MT2 and CT1 treatments. Morphological and histological examination revealed significant difference (p<0.05) in phenotypic males of Nile tilapia fed with the highest percent in MT-treated diet (MT2) of 95±0.58a while MT1, CT2 and CT1 had males of 85±6.0b, 70±5.0b and 65±6.5b, respectively. It was concluded that synthetic androgen (17αMT) was more effective for masculinization but natural androgen scan be an alternative method to produce male tilapia population in an environment-friendly manner as they are inexpensive, eco-friendly, and radially available. These results suggested that synthetic and natural androgen supplementation in the diet plays a significant role in improving growth performance and body composition.

Asunto(s)

RESUMEN

PURPOSE: Colorectal cancer (CRC) is one of the most widely diagnosed cancers in men and women worldwide. With the advancement of next-generation sequencing technologies, many studies have highlighted the involvement of long non-coding RNAs (lncRNAs) in cancer development. Growing evidence demonstrates that lncRNAs play crucial roles in regulating gene and protein expression and are involved in various cancers, including CRC. The field of lncRNAs is still relatively new and a lot of novel lncRNAs have been discovered, but their functional roles are yet to be elucidated. This study aims to characterize the expression and functional roles of a novel lncRNA in CRC. METHOD: Several methods were employed to assess the function of LOC285629 such as gene silencing, qPCR, proliferation assay, BrdU assay, transwell migration assay, ELISA and protein profiler. RESULTS: Via in silico analyses, we identified significant downregulation of LOC285629, a novel lncRNA, across CRC stages. LOC285629 expression was significantly downregulated in advanced stages (Stage III and IV) compared to Stage I (Kruskal-Wallis Test; p = 0.0093). Further in-house validation showed that the expression of LOC285629 was upregulated in colorectal cancer tissues and cell lines compared to the normal counterparts, but was downregulated in advanced stages. By targeting LOC285629, the viability, proliferative abilities, invasiveness and resistance of colorectal cancer cells towards 5-fluorouracil were reduced. It was also discovered that LOC285629 may regulate cancer progression by targeting several different proteins, namely survivin, BCL-xL, progranulin, PDGF-AA, enolase 2 and p70S6 K. CONCLUSION: Our findings suggest that LOC285629 may be further developed as a potential therapeutic target for CRC treatment.

Asunto(s)